Ellis Andrea

CIK 00018776801 companyPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001877680

Recent Transactions

16 trades

Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-08-05$16.75/sh+17,167→ 35,756 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2025-08-05−17,167→ 34,334 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-08-05$49.00/sh−17,167→ 18,589 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-20+6,589→ 18,589 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2025-04-14−10,000→ 64,921 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-04-14$35.00/sh−10,000→ 12,000 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-04-14$8.45/sh+10,000→ 22,000 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2025-04-01−30,000→ 74,921 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-04-01$8.45/sh+30,000→ 42,000 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-04-01$34.05/sh−30,000→ 12,000 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2022-06-22+104,921→ 104,921 total
Purchase
BridgeBio Pharma, Inc.$BBIO
Common Stock
2022-03-15$8.39/sh+12,000→ 12,000 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2021-08-17+49,869→ 49,869 total

Companies

BridgeBio Pharma, Inc.
Director
$BBIO

Recent Filings

Address

C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250

PALO ALTO, CA, 94304

View on SEC.gov